相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Three-year durable efficacy of dolutegravir plus lamivudine in antiretroviral therapy - naive adults with HIV-1 infection
Pedro Cahn et al.
AIDS (2022)
Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in people living with HIV-1
Itzchak Levy et al.
CLINICAL MICROBIOLOGY AND INFECTION (2021)
Brief Report: Virologic Response by Baseline Viral Load With Dolutegravir Plus Lamivudine vs Dolutegravir Plus Tenofovir Disoproxil Fumarate/Emtricitabine: Pooled Analysis
Joseph Eron et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2020)
Optimizing Treatment for Adults with HIV/AIDS in China: Successes over Two Decades and Remaining Challenges
Wei Cao et al.
CURRENT HIV/AIDS REPORTS (2020)
Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults 2020 Recommendations of the International Antiviral Society-USA Panel
Michael S. Saag et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials
Pedro Cahn et al.
LANCET (2019)
Late for testing, early for antiretroviral therapy, less likely to die: results from a large HIV cohort study in China, 2006-2014
Houlin Tang et al.
BMC INFECTIOUS DISEASES (2018)
Current and emerging two-drug approaches for HIV-1 therapy in ART-naive and ART-experienced, virologically suppressed patients
Barbara Rossetti et al.
EXPERT OPINION ON PHARMACOTHERAPY (2018)
ACTG A5353: A Pilot Study of Dolutegravir Plus Lamivudine for Initial Treatment of Human Immunodeficiency Virus-1 (HIV-1)-infected Participants With HIV-1 RNA < 500 000 Copies/mL
Babafemi O. Taiwo et al.
CLINICAL INFECTIOUS DISEASES (2018)
Dolutegravir-lamivudine as initial therapy in HIV-1 infected, ARV-naive patients, 48-week results of the PADDLE (Pilot Antiretroviral Design with Dolutegravir LamivudinE) study
Pedro Cahn et al.
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (2017)
Dual antiretroviral therapy: finding a place in the battle
Daniel Podzamczer et al.
LANCET HIV (2016)
分享论文
